Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Jason, Asselin"'
Autor:
Jane S Hocking, Margaret Hellard, Douglas Boyle, Jo-Anne Manski-Nankervis, Lena Sanci, Alexander Thompson, Joseph S Doyle, Jason Asselin, Mark A Stoové, Jack Wallace, Dina Moussa, Long Nguyen, Zina Valaydon, Marvad Ahad, Susanne Glasgow, Kate New, Jess Howell
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Introduction Despite the availability of effective, subsidised hepatitis B treatment, linkage to care and treatment rates remain very low globally. In Australia, specially trained primary care physicians (general practitioner, GPs) can prescribe hepa
Externí odkaz:
https://doaj.org/article/9b46fc000f64479a86e139e17c203282
Autor:
Daniela K. van Santen, Rachel Sacks-Davis, Ashleigh Stewart, Anders Boyd, Jim Young, Marc van der Valk, Colette Smit, Andri Rauch, Dominique L. Braun, Inmaculada Jarrin, Juan Berenguer, Jeffrey V. Lazarus, Karine Lacombe, Maria-Bernarda Requena, Linda Wittkop, Olivier Leleux, Dominique Salmon, Fabrice Bonnet, Gail Matthews, Joseph S. Doyle, Tim Spelman, Marina B. Klein, Maria Prins, Jason Asselin, Mark A. Stoové, Margaret Hellard
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101810- (2023)
Summary: Background: Broad direct-acting antiviral (DAA) access may reduce hepatitis C virus (HCV) incidence through a “treatment as prevention” (TasP) effect. We assessed changes in primary HCV incidence following DAA access among people living
Externí odkaz:
https://doaj.org/article/659605e137e54320885128beb757fa9d
Autor:
Jack E Heron, Hamish McManus, Tobias Vickers, Kathleen Ryan, Edwina Wright, Allison Carter, Mark Stoove, Jason Asselin, Andrew Grulich, Basil Donovan, Rebecca Guy, Rick Varma, Marcus Chen, Nathan Ryder, David A Lewis, David J Templeton, Catherine C O'Connor, David M Gracey, ACCESS Collaboration
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0280339 (2023)
BackgroundTenofovir disoproxil fumarate (TDF) is associated with adverse renal outcomes when prescribed for HIV infection. There are few data concerning real-world renal outcomes amongst patients prescribed TDF for pre-exposure prophylaxis (PrEP).Met
Externí odkaz:
https://doaj.org/article/4521ee89fb3946b4b84878b76f901cae
Autor:
Allison Carter, Hamish McManus, James S Ward, Tobias Vickers, Jason Asselin, Greta Baillie, Eric PF Chow, Marcus Y Chen, Christopher K Fairley, Christopher Bourne, Anna McNulty, Phillip Read, Kevin Heath, Nathan Ryder, Jenny McCloskey, Christopher Carmody, Heather McCormack, Kate Alexander, Dawn Casey, Mark Stoove, Margaret E Hellard, Basil Donovan, Rebecca J Guy
Publikováno v:
Medical Journal of Australia. 218:223-228
Autor:
Tafireyi Marukutira, Richard T Gray, Caitlin Douglass, Carol El-Hayek, Clarissa Moreira, Jason Asselin, Basil Donovan, Tobias Vickers, Tim Spelman, Suzanne Crowe, Rebecca Guy, Mark Stoove, Margaret Hellard
Publikováno v:
PLoS Medicine, Vol 17, Iss 3, p e1003044 (2020)
BACKGROUND:Globally, few studies compare progress toward the Joint United Nations Program on HIV/AIDS (UNAIDS) Fast-Track targets among migrant populations. Fast-Track targets are aligned to the HIV diagnosis and care cascade and entail achieving 90-
Externí odkaz:
https://doaj.org/article/c8b42d337f8345d6be60ca8a4b78dfd4
Autor:
Michael W Traeger, Alisa E Pedrana, Daniela K van Santen, Joseph S Doyle, Jessica Howell, Alexander J Thompson, Carol El-Hayek, Jason Asselin, Victoria Polkinghorne, Dean Membrey, Fran Bramwell, Allison Carter, Rebecca Guy, Mark A Stoové, Margaret E Hellard, EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Blood-borne Viruses and Sexually Transmitted Infections (ACCESS)
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0235445 (2020)
BackgroundHepatitis C elimination will require widespread access to treatment and responses at the health-service level to increase testing among populations at risk. We explored changes in hepatitis C testing and the cascade of care before and after
Externí odkaz:
https://doaj.org/article/b727f03c1554454dbb509a16037b940d
Autor:
Mark Stoové, Jason Asselin, Alisa Pedrana, Toby Lea, Margaret Hellard, David Wilson, Garrett Prestage, John de Wit, Martin Holt
Publikováno v:
Australian and New Zealand Journal of Public Health, Vol 42, Iss 1, Pp 57-61 (2018)
Abstract Objective: To measure changes in undiagnosed HIV among gay and bisexual men (GBM) in Melbourne. Methods: Undiagnosed HIV was compared between GBM recruited anonymously in 2008 in gay venues only and GBM anonymously or confidentially (results
Externí odkaz:
https://doaj.org/article/36d063964b734368bd002e12349208e2
Autor:
Denton Callander, Hamish McManus, Richard T Gray, Andrew E Grulich, Andrew Carr, Jennifer Hoy, Basil Donovan, Christopher K Fairley, Martin Holt, David J Templeton, Siaw-Teng Liaw, James H McMahon, Jason Asselin, Kathy Petoumenos, Margaret Hellard, Alisa Pedrana, Julian Elliott, Phillip Keen, Jane Costello, Richard Keane, John Kaldor, Mark Stoové, Rebecca Guy
Publikováno v:
The Lancet HIV.
Autor:
Vincent J Cornelisse, Jason Asselin, Dean Murphy, Michael W Traeger, Anna L. Wilkinson, Mark Stoove, Edwina J. Wright, Kathleen E Ryan, Margaret Hellard
Publikováno v:
AIDS and Behavior. 26:1808-1820
Gay and bisexual men (GBM) who use pre-exposure prophylaxis (PrEP) are at increased risk of sexually transmitted infections (STIs) compared to those who don't use PrEP. Since the implementation of PrEP in Australia, it is possible that attitudes towa
Autor:
Kathleen E. Ryan, Anne Mak, Mark Stoove, Brian Price, Christopher K. Fairley, Simon Ruth, Luxshimi Lal, Jason Asselin, Carol El-Hayek, Long Nguyen, Colin Batrouney, David Wilson, John Lockwood, Dean Murphy, Vincent J. Cornelisse, Norman Roth, Jeff Willcox, Christina C. Chang, Judy Armishaw, Ban K. Tee, Matthew Penn, George Forgan-Smith, Christopher Williams, Jeff Montgomery, Kat Byron, Alison Coelho, Brent Allen, Jeremy Wiggins, Jenny Kelsall, Olga Vujovic, Michael West, Anna B. Pierce, Daniel Gallant, Charlotte Bell, John B. F. de Wit, Jennifer F. Hoy, Steve L. Wesselingh, Robert M. Grant, Edwina J. Wright
Publikováno v:
Frontiers in Public Health, Vol 6 (2018)
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV transmission in people at high risk of HIV acquisition. PrEP is highly efficacious when taken either daily, or in an on-demand schedule. In Australia
Externí odkaz:
https://doaj.org/article/99a750e5549a44888f72a8203fde0c2a